Nathan B Fountain insider trades

Open-market stock purchases and sales by Nathan B Fountain, Director at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 30, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -86%.

Recent trades

DateStockTradeValue
Jun 9, 2026ABOS Acumen Pharmaceuticals, IncSold$14.3K
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jun 3, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ABOS Acumen Pharmaceuticals, Inc: 1 buy, 1 sale, last Jun 9, 2026

Get free alerts when Nathan B Fountain files a new trade →